Masahito Morimoto

479 total citations
16 papers, 392 citations indexed

About

Masahito Morimoto is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cognitive Neuroscience. According to data from OpenAlex, Masahito Morimoto has authored 16 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 3 papers in Cognitive Neuroscience. Recurrent topics in Masahito Morimoto's work include Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Child Nutrition and Feeding Issues (3 papers). Masahito Morimoto is often cited by papers focused on Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Child Nutrition and Feeding Issues (3 papers). Masahito Morimoto collaborates with scholars based in Japan and France. Masahito Morimoto's co-authors include Monique Gentil, H Rouach, Virginie Fataccioli, Roger Nordmann, Samuel W. French, Toshiaki Hashimoto, Shojiro Kyotani, Toru Kishimoto, Akira Wanikawa and Minoru Kobayashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Masahito Morimoto

15 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahito Morimoto Japan 9 111 108 73 67 67 16 392
Carmen Colica Italy 14 45 0.4× 147 1.4× 81 1.1× 19 0.3× 54 0.8× 17 710
Sang Mee Hong South Korea 16 119 1.1× 237 2.2× 77 1.1× 58 0.9× 76 1.1× 20 703
Marzieh Kafeshani Iran 15 102 0.9× 118 1.1× 36 0.5× 87 1.3× 34 0.5× 40 569
B. Bałasińska Poland 15 54 0.5× 130 1.2× 33 0.5× 32 0.5× 50 0.7× 33 584
Pritsana Piyabhan Thailand 10 26 0.2× 119 1.1× 46 0.6× 44 0.7× 36 0.5× 34 409
Firouz Ghaderi Pakdel Iran 14 63 0.6× 207 1.9× 41 0.6× 43 0.6× 23 0.3× 46 675
Mariana Liza Spain 4 46 0.4× 118 1.1× 55 0.8× 55 0.8× 17 0.3× 5 580
Yoshihiko Minegishi Japan 13 49 0.4× 227 2.1× 99 1.4× 103 1.5× 27 0.4× 29 697
Francisco Arnaldo Viana Lima Brazil 9 98 0.9× 95 0.9× 22 0.3× 23 0.3× 17 0.3× 15 409
Alireza Malayeri Iran 15 61 0.5× 120 1.1× 16 0.2× 92 1.4× 31 0.5× 41 582

Countries citing papers authored by Masahito Morimoto

Since Specialization
Citations

This map shows the geographic impact of Masahito Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahito Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahito Morimoto more than expected).

Fields of papers citing papers by Masahito Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahito Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahito Morimoto. The network helps show where Masahito Morimoto may publish in the future.

Co-authorship network of co-authors of Masahito Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masahito Morimoto. A scholar is included among the top collaborators of Masahito Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahito Morimoto. Masahito Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Morimoto, Masahito, et al.. (2023). Study on oxidative stress and inflammatory/antioxidant substance levels in autism spectrum disorder. Journal of the Chinese Medical Association. 86(5). 489–493. 6 indexed citations
3.
Morimoto, Masahito, et al.. (2020). Assessment of oxidative stress in autism spectrum disorder using reactive oxygen metabolites and biological antioxidant potential. PLoS ONE. 15(5). e0233550–e0233550. 23 indexed citations
5.
Morimoto, Masahito, et al.. (2020). Three cases in which drug‐induced hyponatremia was improved by replacing carbamazepine with lacosamide. SHILAP Revista de lepidopterología. 8(7). 1166–1170. 3 indexed citations
6.
Morimoto, Masahito, et al.. (2019). Evaluation of oxidative stress and antioxidant capacity in healthy children. Journal of the Chinese Medical Association. 82(8). 651–654. 24 indexed citations
7.
Morimoto, Masahito, et al.. (2017). Impact of Oxidative Stress and Newer Antiepileptic Drugs on the Albumin and Cortisol Value in Severe Motor and Intellectual Disabilities With Epilepsy. Journal of Clinical Medicine Research. 10(2). 137–145. 16 indexed citations
8.
Morimoto, Masahito, et al.. (2017). Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome. Journal of Clinical Pharmacy and Therapeutics. 43(4). 571–573. 8 indexed citations
9.
Ishida, Shiro, et al.. (2016). Assessment of Drug Loss and Variation in Divided Weight after Dispensing a Pediatric Dose of E Keppra<sub>®</sub> Dry Syrup 50%. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 42(1). 40–47.
10.
Morimoto, Masahito, et al.. (2016). A study of oxidative stress and the newer antiepileptic drugs in epilepsy associated with severe motor and intellectual disabilities. Journal of the Chinese Medical Association. 80(1). 19–28. 7 indexed citations
11.
Morimoto, Masahito, et al.. (2016). Oxidative Stress Measurement and Prediction of Epileptic Seizure in Children and Adults With Severe Motor and Intellectual Disabilities. Journal of Clinical Medicine Research. 8(6). 437–444. 11 indexed citations
12.
Morimoto, Masahito, et al.. (2016). Epilepsy Properties and Seizure Suppression in a Severe Motor and Intellectual Disabilities. International Journal of Clinical Medicine. 7(3). 182–192. 5 indexed citations
13.
Sakaue, Shinji, et al.. (2012). [A case with recurrent asystole due to breath-holding spells: successful treatment with levetiracetam].. PubMed. 44(6). 496–8. 2 indexed citations
14.
Morimoto, Masahito, et al.. (2009). Effects of Bordeaux Mixture (Copper Sulfate) Treatment on Blackcurrant/Muscat-Like Odors in Hops and Beer. Journal of the American Society of Brewing Chemists. 68(1). 30–33. 17 indexed citations
15.
Kishimoto, Toru, et al.. (2008). Behaviors of 3-Mercaptohexan-1-ol and 3-Mercaptohexyl Acetate during Brewing Processes. Journal of the American Society of Brewing Chemists. 66(3). 192–196. 40 indexed citations
16.
Rouach, H, Virginie Fataccioli, Monique Gentil, et al.. (1997). Effect of Chronic Ethanol Feeding on Lipid Peroxidation and Protein Oxidation in Relation to Liver Pathology. Hepatology. 25(2). 351–355. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026